[Establishment and characterization of human cholaginocarcinoma, MEC, producing carbohydrate antigen 19-9]. 1990

K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
First Department of Surgery, Marianna University School of Medicine, Kawasaki, Japan.

A new tumor cell line MEC was established from pleural effusion of a patient of cholaginocarcinoma. In tissue culture, the cell line grew in the sheet of variant cells and showed the epithelial-like pattern. Histologically, the cell line almost showed the same pattern as those in bile and preural effusion from the patient. Electron microscopic observation of this cell line showed the irregular microvilli on the surface of the cell and the desmosome between cells. The doubling time of the cell line was 40.8 hours. Chromosome counts ranged from 61 to 86. The cell line had 9 marker chromosomes and some variant chromosomes. The cell line was transplanted into the subcutaneous of nude mice and formed the tumor. It showed the moderately differentiated tubular adenocarcinoma the same pattern as the primary tumor. We have recognized the producing and releasing of CA19-9 in the serum from the tumor bearing nude mouse and supernate of the medium as the serum from the patient. The presentation of CA19-9 in the cytosol of the cell line and the tumor cells of nude mouse was recognized in Avidin-Biotin-Peroxidase Complex in immunoloperoxidase techniques. The cell line can grow in serum-free medium. On September, 1990, the cell line has been maintained from 70 passages during about 800 days.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008297 Male Males
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002759 Adenoma, Bile Duct A benign tumor of the intrahepatic bile ducts. Cholangioma,Adenomas, Bile Duct,Bile Duct Adenoma,Bile Duct Adenomas,Cholangiomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001650 Bile Duct Neoplasms Tumors or cancer of the BILE DUCTS. Bile Duct Cancer,Cancer of Bile Duct,Cancer of the Bile Duct,Neoplasms, Bile Duct,Bile Duct Cancers,Bile Duct Neoplasm,Cancer, Bile Duct,Cancers, Bile Duct,Neoplasm, Bile Duct
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
March 1990, Human cell,
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
March 1991, Human cell,
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
June 1988, Human cell,
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
January 1987, Japanese journal of cancer research : Gann,
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
June 1992, Human cell,
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
June 1992, Internal medicine (Tokyo, Japan),
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
January 2000, Clinical neuropathology,
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
October 1996, Journal of gastroenterology,
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
October 1996, The Journal of urology,
K Yoshida, and H Tomizawa, and T Ota, and T Nagashima, and H Kikuchi, and H Watanabe, and K Hashizaki, and A Yonaha
August 1998, British journal of urology,
Copied contents to your clipboard!